Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications
American Society of Clinical Oncology Educational Book · 2026-06 · 46 (3)
DOI: 10.1200/edbk-26-520792 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2026-06. Verfasst von Justine V Cohen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit nennt 74 Literaturangaben.
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) have transformed the treatment of a broad range of malignancies over the past decade. As the scope of indications and the clinical experience expands, oncologists are increasingly confronted with complex scenarios. This chapter addresses three of the most clinically challenging frontiers in ICI use: the safe and effective application of checkpoint blockade in patients with preexisting autoimmune disease, the evolving toxicity landscape of ICI-based combination regimens including chemotherapy + immune checkpoint inhibition, immune checkpoint inhibition + tyrosine kinase inhibitor, and immune checkpoint inhibition + antibody-drug conjugate, and the emerging evidence supporting ICI in solid organ transplant recipients with advanced malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
- Fox Chase Cancer Center, Philadelphia, PA.
- Westmead and Blacktown Hospitals, Sydney Australia.
- Westmead and Blacktown Hospitals, The Melanoma Institute Australia and the University of Sydney, Sydney Australia.
ORCID-Profile: Justine V Cohen
Zitieren
APA
Cohen, J. V., Adika, A., Zibelman, M., Gallagher, S. J., Khaddour, K., Silk, A. W., & Carlino, M. S. (2026). Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications. American Society of Clinical Oncology Educational Book, 46(3). https://doi.org/10.1200/edbk-26-520792
Vancouver
Cohen JV, Adika A, Zibelman M, Gallagher SJ, Khaddour K, Silk AW, et al. Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications. American Society of Clinical Oncology Educational Book. 2026;46(3). doi:10.1200/edbk-26-520792
BibTeX
@article{Cohen2026,
author = {Cohen, Justine V and Adika, Adam and Zibelman, Matthew and Gallagher, Stuart J and Khaddour, Karam and Silk, Ann W and Carlino, Matteo S},
title = {Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications},
journal = {American Society of Clinical Oncology Educational Book},
year = {2026},
volume = {46},
number = {3},
doi = {10.1200/edbk-26-520792}
}
EUVIMED